Metazoans secrete an extensive array of small proteins essential for intercellular communication, defense, and physiologic regulation. Their synthesis takes mere seconds, leaving minimal time for recognition by the machinery for cotranslational protein translocation into the ER. The pathway taken by these substrates to enter the ER is not known. Here, we show that both in vivo and in vitro, small secretory proteins can enter the ER posttranslationally via a transient cytosolic intermediate. This intermediate contained calmodulin selectively bound to the signal peptides of small secretory proteins. Calmodulin maintained the translocation competence of small-protein precursors, precluded their aggregation and degradation, and minimized their inappropriate interactions with other cytosolic polypeptide-binding proteins. Acute inhibition of calmodulin specifically impaired small-protein translocation in vitro and in cells. These findings establish a mammalian posttranslational pathway for small-protein secretion and identify an unexpected role for calmodulin in chaperoning these precursors safely through the cytosol.
INTRODUCTION
The first step in eukaryotic protein secretion is translocation into the endoplasmic reticulum (ER). In metazoans, this process usually begins when the signal recognition particle (SRP) recognizes the hydrophobic N-terminal signal sequence of a secretory protein as it emerges from the ribosome (Shan and Walter, 2005 ). An interaction between SRP and the SRP receptor facilitates targeting of the ribosome-nascent chain complex to the ER, where the ribosome docks onto the Sec61 protein-conducting channel (Osborne et al., 2005) . Subsequent translocation is coupled to translation, with the polypeptide passing through the Sec61 channel as it emerges from the ribosomal exit tunnel. The signal sequence is removed during translocation and the translocated mature domain then traffics through the secretory pathway for extracellular secretion. This cotranslational translocation pathway is conserved from bacteria to mammals and is used by most secretory and membrane proteins (Rapoport, 2007) .
However, secretory proteins smaller than 100 residues (Table S1 available online) might complete translation before efficient cotranslational targeting (Goder et al., 2000; Zimmermann and Mollay, 1986; Zimmermann et al., 1990) . This is due to a limited amount of time between when the signal sequence is available for SRP recognition and when the termination codon is reached. Whether such short proteins can access the cotranslational pathway therefore depends on whether this time window is sufficient for SRP recognition, targeting to its receptor, transfer to the Sec61 translocon, and insertion into the channel. If this window is too short, then small proteins would be released into the cytosol and need to enter the ER posttranslationally, a process that is poorly understood in metazoans.
Thus, a decisive question in understanding short protein biosynthesis is whether targeting can reasonably occur during its synthesis. Direct estimates of targeting kinetics in vivo suggest that an average of ten seconds is needed to target even a highly robust SRP-dependent signal (Goder et al., 2000) . This means that after a signal sequence first emerges from the ribosome at 60 residues of synthesis ( Figure S1A ), targeting may not occur for another 60 residues (assuming translation at 6 residues/sec). A significant proportion of proteins shorter than 120 residues would therefore terminate translation before they are targeted. While selective mRNA localization or exceptionally strong translational arrest could conceivably overcome these temporal constraints ( Figure S1B ), these potential mechanisms are poorly characterized. Thus, short precursors may well need to use posttranslational translocation to enter the ER efficiently.
Posttranslational ER translocation has been most extensively studied in yeast (Panzner et al., 1995b) , where the pathway is utilized by secretory proteins containing modestly hydrophobic signal sequences that cannot engage SRP effectively (Ng et al., 1996) . In this pathway, it is thought that general cytosolic chaperones, most notably of the Hsp70 family, interact with and maintain translocation competence of fully-synthesized substrates in the cytosol (Chirico et al., 1988; Deshaies et al., 1988) . Upon release from the chaperones, substrates engage the heptameric Sec complex at the ER. This translocon is composed of the Sec61 complex associated with the Sec62/63/ 71/72 complex (Deshaies et al., 1991; Panzner et al., 1995a) . Substrates that enter the Sec translocon are made accessible to lumenal Kar2 (an Hsp70 family member), which, via cycles of ATPase-driven binding and release, ''ratchets'' the polypeptide across the membrane (Brodsky and Schekman, 1993; Matlack et al., 1999; Panzner et al., 1995a) . Thus, the general paradigm is one of substrate chaperoning in the cytosol, engagement of a membrane-bound channel, and biased translocation via a lumenal polypeptide-binding protein.
Although all of the components in this pathway are conserved in mammals, such posttranslational translocation has not been studied extensively. Notably, classical yeast posttranslational substrates, such as prepro-a-factor, can only translocate cotranslationally across mammalian ER membranes (Garcia and Walter, 1988) . It was therefore surmised that in higher eukaryotes, the SRP-dependent cotranslational pathway predominantes and has evolved to accommodate a wider range of substrates than in yeast. The main posttranslational models analyzed thus far in mammalian systems have been short secreted proteins (Schlenstedt and Zimmermann, 1987; Schlenstedt et al., 1992; Zimmermann and Mollay, 1986) . While they were observed to translocate posttranslationally in vitro, the cellular machinery and mechanisms involved have been unclear. Here, we demonstrate that both in vivo and in vitro, a substantial proportion of short secretory proteins normally utilize posttranslational translocation to enter the ER. Mechanistic analysis of this pathway in vitro revealed a conceptually similar logic to the yeast posttranslational system. However, we discovered an unexpected function for calmodulin in recognizing short protein precursors and chaperoning them through the cytosol. Remarkably, calmodulin's role in protecting short proteins from irreversible off-pathway fates such as ubiquitination and aggregation could not be fully compensated by other cytosolic chaperones.
RESULTS AND DISCUSSION
Development of an Assay to Detect Posttranslational Translocation To determine whether posttranslational translocation occurs in mammalian cells under physiologically normal conditions, we developed an assay to detect a putative cytosolic translocation intermediate with high specificity and sensitivity. To do this, we determined whether a 15-residue biotin acceptor epitope (BioTag) near the C terminus of a short protein was accessible to cytosolic biotin ligase (BirA) before its translocation into the ER ( Figure 1A ). Because the BioTag epitope would be deep inside the ribosome when the termination codon is reached, cotranslational (i.e., ribosome-coupled) translocation would preclude its access to BirA. By contrast, a biotinylated signalcleaved product would be a signature of posttranslational translocation that necessarily involved a BirA-accessible cytosolic intermediate.
Our model short protein was Cecropin A (CecA), a secreted antimicrobial peptide derived from a 64-residue precursor. Prolactin (Prl) served as a well-established cotranslationally translocated model. Each protein was modified to contain a BioTag-HA epitope ( Figure 1B ) and the experimental strategy was characterized in vitro. When synthesized in rabbit reticulocyte lysate (RRL), the BioTagged version of CecA could be site-specifically biotinylated by BirA as evidenced by its pulldown with immobilized avidin ( Figure 1C , downward arrowhead). Biotinylation was dependent on both the BioTag and BirA.
When CecA translation reactions were incubated with ERderived rough microsomes (RMs), CecA was translocated into the lumen as judged by both signal sequence cleavage and protease protection ( Figure 1D ). Biotinylated CecA was translocated comparably to nonbiotinylated CecA ( Figure 1E , upward arrowhead), illustrating that the small biotin moiety does not preclude translocation. Cytosolic BirA could not access the substrate after translocation into the ER (Emerman et al., 2010;  data not shown), confirming that biotinylation is cytosol-specific.
A similar analysis of BioTagged Prl showed that in the cytosol, it was biotinylated in a BirA-dependent manner ( Figure 1F , downward arrowhead). Inclusion of RMs during Prl translation resulted in its cotranslational translocation into the lumen, as evidence by its signal cleavage. However, inclusion of BirA during Prl translocation resulted in biotinylation of only the nontranslocated population ( Figure 1F ). Thus, when the ribosome is coupled to the translocon during translocation, the nascent chain is not accessible to BirA in the cytosol. Collectively, these results establish a minimally perturbing, orthogonal, and sitespecific modification that can be used to 'mark' a putative cytosolic intermediate without precluding its subsequent translocation.
Posttranslational Translocation in Mammalian Cells
The biotinylation assay was imported into mammalian cells and the behavior of CecA was analyzed. In pulse-labeled HeLa cells, a signal-cleaved and biotinylated form of BioTagged CecA was observed ( Figure 1G ; upward arrowhead). This product was not released by selective plasma membrane permeabilization with digitonin ( Figure S1C ), confirming its noncytosolic location. CecA had therefore entered the ER (i.e., was signal cleaved), after having been exposed to the cytosol (i.e., was biotinylated). Biotinylation required BirA and was observed in other cell types ( Figure S1D ). In contrast, BioTagged Prl was efficiently translocated, but not biotinylated ( Figure 1H ), as expected for a cotranslationally translocated protein. Thus, CecA can enter the mammalian secretory pathway posttranslationally via a cytosolic intermediate.
Signal sequence swapping experiments showed that both length and signal sequence features influence access to posttranslational translocation. The Prl signal sequence fused to the CecA mature domain (Prl-CecA) supported translocation (as judged by signal cleavage), but little if any of the translocated product was biotinylated ( Figure 1G and Figures S1D and S1E ). When the proteasome was inhibited, biotinylated Prl-CecA precursor was detected ( Figure 1G and Figure S1E ). Thus, the highly efficient cotranslational signal sequence from Prl cannot fully overcome the short kinetic window for SRP-mediated targeting of a small protein. However, even when Prl-CecA precursor was prevented from degradation, biotinylated signalcleaved protein was not observed, suggesting that Prl-CecA is not an efficient posttranslational translocation substrate.
The CecA signal sequence fused to the Prl mature domain (CecA-Prl) was also translocated, but none of the signal-cleaved product was observed to be biotinylated ( Figure 1H ). Biotinylated CecA-Prl precursor was detected with proteasome inhibition, indicating that it is capable of being biotinylated in the cytosol. Thus, both Prl-CecA and CecA-Prl primarily enter the ER cotranslationally, with cytosolically released precursor being degraded by the proteasome instead of being BirA:
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RMs: Figure S1 . translocated posttranslationally. Posttranslational translocation is therefore neither solely encoded in the signal sequence, nor simply a consequence of short precursors. Instead, CecA has evolved a signal sequence that, while sub-optimal for the cotranslational pathway, allows its short passenger to avoid cytosolic quality control ( Figure S1E ) and engage a yet uncharacterized but specific posttranslational translocation pathway. Comparing the relative amounts of biotinylated precursor and translocated product ( Figure 1G and Figure S1E ), we estimate that at least 35% of CecA translocates posttranslationally in mammalian cells. This is probably an underestimate, since biotinylation is not likely to be 100% efficient given the transient nature of the cytosolically accessible intermediate. Thus, in vivo under normal physiological conditions, posttranslational translocation is a substantial mechanism for small-protein entry into the ER.
Reconstitution of Posttranslational Translocation In Vitro
To mechanistically dissect this posttranslational translocation pathway, we studied the process in a reconstituted mammalian in vitro system. Epitope-tagged CecA precursor was synthesized in RRL, further translation was prevented by either removing ribosomes or adding RNase, and the reaction was posttranslationally incubated with RMs. Translocation was assayed by signal sequence cleavage and protease protection assays, while protein interactions were detected by sucrose gradient size fractionation and chemical crosslinking ( Figure 2A ). In our initial studies, posttranslational translocation was inefficient (10%-30% at best; data not shown), similar to previous findings (Schlenstedt et al., , 1992 . Size fractionation and crosslinking studies of the translation products showed that the substrate engaged many different cytosolic complexes of heterogeneous size, only a subset of which were even modestly translocation-competent ( Figure 2B) . Because low-level translocation precluded any substantive mechanistic dissection, we first optimized the system to improve homogeneity of functional CecA complexes and maximize its translocation.
Among the conditions tested, a nonnucleased ''native'' RRL (N-RRL) translation system proved superior. CecA precursor synthesized in N-RRL was substantially more homogeneous on sucrose gradients ( Figure 2C ), with nearly all of the CecA migrating in a few fractions near the top (<60 kD) region of the gradient ( Figure 2D ). Crosslinking analysis also showed much more homogeneity, revealing a single 20 kD interaction partner ( Figure 2C ). Importantly, testing of these CecA-containing fractions for translocation revealed markedly improved efficiency of 60%. Two other short secretory proteins also showed comparably homogenous migration in the same part of the sucrose gradient, and these fractions were active in posttranslational translocation ( Figure S2 ).
With this improved system, we used the BirA-BioTag assay system to determine if the posttranslational pathway is used under conditions where the cotranslational pathway is available. CecA translated in N-RRL supplemented with RMs and BirA was observed to be efficiently translocated ( Figure 2E ). Avidin pulldowns revealed that the translocated population was biotinylated, indicating that the BioTag was accessible to cytosolic BirA before translocation. Because the BioTag is near the C terminus of CecA, we can further conclude that CecA must have terminated translation and emerged from the ribosome before its translocation. Consistent with this conclusion, inactivation of the cotranslational pathway by mild trypsin digestion of RMs had no effect on CecA translocation (data not shown). Additional experiments testing Prl-CecA and CecA-Prl in N-RRL confirmed that posttranslational translocation is both length and signal sequence dependent (data not shown), exactly as observed in vivo. Thus, CecA utilizes posttranslational translocation to enter the microsome lumen even when the cotranslational pathway is available. The N-RRL system therefore recapitulates our in vivo observations in an efficient in vitro system amenable to mechanistic manipulation.
Mapping Small-Protein Interactions during Posttranslational Translocation
To define the main steps of small-protein translocation, we combined temporal staging of the translocation reaction with general and site-specific crosslinking. In the cytosol, chemical crosslinking in N-RRL had revealed that CecA precursor associated almost exclusively with a 20 kD protein (p20) ( Figure 2C ). Upon addition of RMs, the p20 interaction was lost concomitant with substrate translocation ( Figure 3A ). CecA crosslinking after translocation revealed a major 60 kD partner ( Figure 3A ) that fractionated with RMs in sedimentation assays ( Figure 3B ). This crosslink was not observed when reconstituted RMs lacking lumenal proteins (LD-RMs) were used ( Figure 3C ), suggesting that p60 is a lumenal chaperone. We tested several candidates in immunoprecipitation experiments and found p60 to be PDI ( Figure 3D ). Photo-crosslinking with single probes incorporated into CecA confirmed that the PDI interaction is direct and selective to the mature domain (data not shown).
Translocation assays using LD-RMs resulted in signalcleavage but not protease protection of CecA ( Figure 3E ). Similar results were obtained when high pH extraction was used to remove lumenal proteins (data not shown). In addition, while signal-cleaved CecA normally cosediments with intact RMs, signal-cleaved CecA produced with LD-RMs was cytosolic (data not shown). This suggests that in addition to interacting with translocated CecA, lumenal proteins are functionally necessary to complete CecA translocation into the ER lumen. This is similar to other translocation systems where lumenal proteins are thought to bias substrate transport at a late stage of translocation (Brodsky and Schekman, 1993; Nicchitta and Blobel, 1993; Panzner et al., 1995) .
Thus, a cytosolic p20 interaction is converted to a PDI interaction in the ER lumen, presumably separated by the decisive translocation step across the membrane. This suggests that the mammalian small-protein translocation pathway might be conceptually analogous to posttranslational translocation in yeast, where translocation through the Sec61 channel is flanked by interactions with cytosolic and lumenal chaperones. It is therefore possible that CecA translocation could also involve the Sec61 complex given its high conservation (Rapoport, 2007) . Consistent with this idea, we observed partial inhibition of CecA translocation with either a Sec61 inhibitor or competition with ribosomes translating a cotranslational Sec61 substrate (unpublished results). Future studies will be needed to investigate this possibility and rigorously analyze the membrane and lumenal steps in the CecA pathway. For the remainder of this study, we focus on the poorly characterized p20-substrate complex.
Identification of p20 as Calmodulin
In addition to CecA, p20 was the major crosslinking partner of other short secretory proteins, but not of longer secretory proteins ( Figure S2 and data not shown). Furthermore, this interaction was lost upon translocation into RMs and was signal sequence specific since mutating hydrophobic residues in the CecA signal to charged residues prevented p20 association ( Figure 4A) . Importantly, the p20 interaction with CecA was observed to be equally efficient even when CecA was translated at 10-fold lower levels (data not shown). This illustrated that p20 was not a 'secondary' interaction partner seen only after saturating another factor. Thus, for multiple short proteins, p20 is a major and transient signal sequence-dependent interaction partner in the cytosol.
Affinity purification of CecA precursor from large-scale translation reactions copurified p20 in a signal-dependent manner, and mass mapping subsequently identified p20 to be calmodulin (CaM) ( Figure 4B ). Immunoblotting of affinity-purified CecA and immunoprecipitation of CecA crosslinking reactions confirmed that CaM is the primary signal sequence-specific interacting partner in the cytosol ( Figures 4B and 4C ). CaM is an abundant, ubiquitously expressed, and highly conserved protein capable of binding short 7-15 residue peptides of tremendous sequence diversity (O'Neil and DeGrado, 1990) . This promiscuity of CaM is facilitated by a substrate-binding site rich in methionine residues, whose hydrophobic flexible side chains can accommodate widely variable hydrophobic targets. A similar methionine-rich binding pocket is seen in the signal sequence binding domain of SRP (Figures S3A-S3C ) (Keenan et al., 1998) and the transmembrane domain binding region of Get3 (Mateja et al., 2009) . This suggested that CaM can bind directly to the signal sequences of small proteins, a hypothesis validated by site-specific photo-crosslinking experiments ( Figure 4D ). Indeed, CaM was previously observed to bind isolated signal sequences or fragments (Martoglio et al., 1997) , although the relevance of this finding was not clear. Thus, CaM would appear to be a major signal sequence binding protein for small secretory proteins released into the cytosol.
CaM Requires Physiologic [Ca

2+
] for Signal Sequence Interaction Why did our initial crosslinking experiments in RRL fail to reveal CaM interactions? The answer proved to be inhibition of CaM binding to small-protein substrates by exogenously added EGTA. RRL translation systems are typically treated with a Ca 2+ -dependent nuclease to remove endogenous mRNAs, followed by addition of 2 mM EGTA to inactivate the nuclease (Pelham and Jackson, 1976) . This chelates free Ca 2+ , which has four binding sites on CaM, and influences its ability to bind many of its substrates. By contrast, the nonnucleased N-RRL system lacks EGTA, and therefore contains endogenously derived cytosolic Ca 2+ . This suggested that the key feature of N-RRL was the absence of EGTA. Indeed, standard RRL can be 'rescued' in its activity by fractionation to remove the nuclease and EGTA ( Figure S3D ). Like N-RRL ( Figure 2C ), this fractionated RRL (Fr-RRL) shows homogeneous substrate complexes, efficient CaM interaction, and improved CecA translocation ( Figure S3E ). Addition of EGTA (independent of nuclease) to either N-RRL or Fr-RRL ( Figure 4E and data not shown) inhibited substrate interaction with CaM and decreased translocation efficiency ( Figure 4F ). Similar results were seen for two other small proteins (data not shown). Thus, efficient posttranslational translocation and the CaM interaction were previously obscured from discovery by the long-standing practice of treating translation systems with a Ca 2+ -activated nuclease. Although the precise relationship between Ca 2+ binding to the four potential sites of CaM and its activity in signal sequence recognition remains to be fully characterized, CaM interaction and translocation activity were robust at a range of Ca 2+ concentrations that encompasses the physiologic cytosolic Ca 2+ levels found in N-RRL. However, either Ca 2+ chelation with > 10 mM EGTA or excess Ca 2+ > 10 mM resulted in reduced CecA translocation ( Figure 4F ). Crosslinking analysis showed that with EGTA, CaM is unable to interact with translocation substrates, whereas excessively high Ca 2+ concentrations preclude efficient CaM release from translocation substrates when RMs were added ( Figure 4G ). These experiments illustrate that unlike a canonical CaM interaction that is only induced upon Ca 2+ influx into the cytosol, CaM binding and release from signal sequences is fully operational at basal cytosolic Ca 2+ concentration. Such a 'constitutive' activity was important in postulating a physiologic role in translocation, since our in vivo studies were performed under normal conditions where cytosolic [Ca 2+ ] would be 10-100 nM (Carafoli, 1987) . Thus, although CaM would seem to be an unlikely component of a constitutive cellular pathway, its ability to operate at widely ranging [Ca 2+ ], signal sequence selectivity, ubiquity, abundance, and flexible nature of its hydrophobic binding site all support a direct functional role in posttranslational translocation.
Calmodulin Is Required for Efficient Posttranslational Translocation
To directly test this, we selectively depleted CaM from N-RRL by passing the lysate over a resin of immobilized CaM binding peptide (Means et al., 1991 ; Figure 5A ). Depletion was better than 90% as judged by both immunoblotting and undetectable CaM-CecA crosslinks ( Figures 5A and 5B ). Relative to mockdepleted lysate, CaM-depleted lysates were selectively diminished in posttranslational CecA translocation with no discernable effect on cotranslational Prl translocation ( Figures 5C and 5D ). This deficiency was fully rescued by adding back physiologic levels of recombinant CaM, which interacted effectively with small substrates ( Figure 5B) . Importantly, the levels of other cytosolic chaperones, such as Hsp70, were unchanged after CaM depletion (data not shown). Furthermore, CecA translocation was reduced in CaM depleted lysates even when RMs were included cotranslationally ( Figure S4A ), showing that neither cytosolic chaperones nor the cotranslational pathway can fully replace CaM's role.
To examine the importance of CaM in vivo, we used two independent membrane-permeable CaM inhibitors, E6 Berbamine and Ophiobolin A. In vitro studies verified that both inhibit CaM binding to CecA (data not shown). When applied to HeLa cells, both inhibitors reduced CecA translocation as judged by the relative ratio of precursor to signal-cleaved forms recovered from pulse-labeled cells ( Figure 5E ). As expected, neither inhibitor had an effect on Prl translocation ( Figure S4B ). Because the inhibitors were applied acutely during the labeling period, potential indirect effects were minimized. Thus, CecA apparently cannot effectively utilize either the SRP-dependent cotranslational pathway or other chaperones when CaM is inhibited in vivo. This suggests that a substantial proportion of CecA follows the CaM-dependent posttranslational pathway.
Calmodulin Maintains Translocation Competence of Small Proteins
To understand the mechanism by which CaM facilitates posttranslational translocation, we analyzed substrate fate in the presence and absence of CaM. We found that for several small secretory proteins, CaM's role was to prevent their heterogeneous engagement into various high molecular weight complexes, including possible aggregation ( Figure 6A ). This was observed not only with EGTA (e.g., Figure 2 and Figure S2 ), but also with selective CaM depletion ( Figure 6A ). In addition, small proteins bound to CaM retained their translocation competence over the course of an hour, but lost competence rapidly after CaM dissociation with EGTA ( Figure 6B ). This loss of translocation competence was largely irreversible since subsequent restoration of Ca 2+ could not effectively rescue CecA translocation ( Figure 6C ). Instead, substrates forcibly dissociated from CaM made various off-pathway interactions as detected by crosslinking. Among these interactions, one binding partner was Bag6 (data not shown), a hydrophobic domain binding protein that was recently shown to be a quality control factor for degrading mislocalized proteins (Hessa et al., 2011) . Indeed, small-protein precursors are more extensively ubiquitinated in the absence compared to presence of CaM activity ( Figure 6D ). Thus, CaM binding to short secretory proteins protects their hydrophobic signal sequences from terminal off-pathway fates, thereby maintaining their solubility and translocation competence.
Calmodulin Dissociation Is Rate Limiting for Translocation
Since CaM does not accompany its substrate into the ER lumen, it must release substrate for translocation to occur. A key issue is how this release is effected. One possibility is that CaMsubstrate interactions are dynamic and that the unbound population of substrate is able to engage the translocation machinery. Alternatively, release might be mediated by a putative receptor on the RMs, with CaM therefore playing the role of a specific targeting factor. Indeed, CaM was recently found to interact with Sec61a (Erdmann et al., 2011) , which would provide an attractive targeting mechanism for small-protein substrates. To discriminate between these models, we analyzed the nature of CaM-substrate interaction dynamics. We found that in the cytosol (without RMs), the CecA-CaM complex was dynamic. This was illustrated by the finding that addition of recombinant GST-CaM to pre-formed CecA-CaM complexes results in CecA equilibration between the endogenous and recombinant CaM ( Figure 7A) . A time course using photo-crosslinking showed that transfer from CaM to GSTCaM began within five minutes and equilibrated with a time course that closely matched the time course for posttranslational translocation ( Figure 7B ). This suggested that the intrinsic rate of release from CaM may be the rate-limiting event for posttranslational translocation. To test this, we asked what would happen if substrate release from CaM were prematurely induced. In the spontaneous release model, this should increase the rate of substrate translocation. By contrast, a receptor-mediated model would predict decreased translocation since the substrate would no longer be bound to its targeting factor. CaM-CecA complexes were dissociated with EGTA in the presence of RMs and the extent of translocation at multiple time points was assessed ( Figure 7C) . A clear acceleration of rate was observed under these conditions, with translocation being nearly complete within 5 min. Note that the converse is also true: slowing down substrate release from CaM by increased Ca 2+ levels leads to reduced translocation ( Figure 4F and 4G). Thus, at least under the conditions of this N-RRL in vitro system, CaM binding to substrates is dynamic, and the rate-limiting step in translocation is determined by the kinetics of substrate release. While a receptor does not seem to be obligatory, it could nonetheless improve efficiency or reduce off-pathway reactions by favoring substrate release close to its site of translocation. This remains to be investigated, particularly the intriguing interaction between Sec61a and CaM (Erdmann et al., 2011 ). 
Conclusions and Perspective
While short secreted proteins were once considered unusual, they are now appreciated to serve a wide range of functions in metazoans. Notable examples include antimicrobial peptides essential for innate immunity, various toxins, hormones, chemokines, and others whose precursors are encoded by short open reading frames (Brogden, 2005; Schluger and Rom, 1997;  Table  S1 ). In addition, recent ribosome profiling analyses (Ingolia et al., 2009) and bioinformatic studies (Frith et al., 2006) indicate that many short proteins remain unannotated and that a significant portion of these may contain hydrophobic signal sequences for targeting to the secretory pathway. Our results provide new mechanistic insights into how small secretory proteins enter the mammalian ER.
We have illustrated both in vitro and in vivo that short proteins utilize a posttranslational translocation pathway and identify CaM as a specific chaperone that stabilizes the cytosolic intermediate in this process ( Figure 7D ). CaM directly binds to the hydrophobic signal sequences of short secretory proteins in a Ca 2+ -regulated manner, shielding them from detrimental fates in the aqueous cytosol, preventing their recognition by quality control, and maintaining their ability to translocate. This pathway fills a niche that cannot be fully accommodated by either the SRP-dependent cotranslational pathway or general cytosolic chaperones. Hence, even under cotranslational translocation conditions in vitro or in vivo, a substantial amount of translocated CecA was derived from a cytosolic intermediate. Furthermore, selective depletion or inhibition of CaM substantially reduced small-protein translocation and increased off-pathway fates. Thus, CaM-dependent translocation is a major (but perhaps not exclusive) pathway used by small proteins.
The observation that CaM depletion (or inhibition) could not be readily compensated by other abundant polypeptide binding proteins was unexpected. This differs from yeast, where multiple chaperones, most notably of the Hsp70 family, interact with and maintain translocation competence of substrates. The mammalian orthologs of these chaperones are clearly functional since a yeast substrate (prepro-a-factor) synthesized in nucleased RRL can interact with them and posttranslationally translocate into yeast RMs (Plath and Rapoport, 2000; Rothblatt et al., 1987) . So why are the mammalian orthologs of these chaperones unable to fulfill the same function for small proteins? One reason might be the need for more complete shielding of the hydrophobic signal sequence to prevent aggregation. Indeed, substrates engage in large translocation-incompetent complexes in the absence of CaM, despite the availability of the full complement of cytosolic chaperones. This might not be a problem in yeast where posttranslational substrates typically have signal sequences of lower hydrophobicity (Ng et al., 1996) , and any aggregation can be reversed by Hsp104, a fungal specific chaperone (Doyle and Wickner, 2009) .
In addition, metazoans often couple their chaperone systems more directly to ubiquitination pathways (Hessa et al., 2011; McConough and Patterson, 2003) . Hence, CaM can maintain its substrates in a translocation competent state without the (C) CecA-CaM complexes made in N-RRL were dissociated with 0.5 mM EGTA in the presence of RMs, incubated for varying times, and analyzed by SDS-PAGE. Translocation occurs within 5 min after EGTA dissociation but is normally slower at endogenous Ca 2+ levels.
(D) Working model. Small proteins have poor access to cotranslational translocation, but instead interact dynamically with CaM in the cytosol. This prevents degradation and aggregation, while still allowing translocation to occur upon CaM release. See Table S1 for examples of small secretory proteins that may use this pathway.
risk of rapid degradation. Consistent with this idea, small-protein substrates are ubiquitinated in vitro in the absence of CaM, and CaM-independent precursors (but not CaM-dependent ones) are rapidly degraded in a proteasome-dependent pathway in vivo. Thus, while general cytosolic chaperones can maintain translocation competence of small proteins in principle, CaM's signal sequence selectivity, ability to completely wrap around and shield its substrate, and lack of coupling to ubiquitination machinery all afford advantages. Finally, high volume secretion of small proteins, such as insulin and beta-defensin-2, are often accompanied by significant changes in intracellular Ca 2+ levels that directly affect secretion in multiple ways including transcription, translation, and trafficking (German et al., 1990; Krisanaprakornkit et al., 2003; Pernet et al., 2003) . This imposes rapid and very large changes in translocation load without sufficient time to increase translocon abundance. It is attractive to speculate that the ability of CaM to efficiently maintain translocation competence, particularly under high Ca 2+ conditions, may buffer against temporary increases in small-protein production without having to degrade the excess. Given that CaM is the target of much regulation, one might also anticipate that small-protein secretion could be responsive to changing needs and extracellular cues.
EXPERIMENTAL PROCEDURES Reagents and Standard Methods
All plasmid constructs have been described or are minor modifications to existing constructs produced using standard methods (Stefanovic and Hegde, 2007; Emerman et al., 2010) . CaM antibody was obtained from Abcam. All other antibodies, in vitro translations and biotinylation, sucrose gradients, chemical crosslinking, photocrosslinking, immunoblotting, affinity purification, immunoprecipitations, and avidin pulldowns have been described (Stefanovic and Hegde, 2007; Emerman et al., 2010; Hessa et al., 2011; Fons et al., 2003; Do et al., 32) . Culture, transfection, and pulse-chase analysis of HeLa and 293T were as before (Emerman et al., 2010) . Recombinant His-tagged and GST-tagged CaM, His-tagged BirA, and GST-tagged CaM binding peptide were purified from E. coli using standard procedures. Details are provided in the Extended Experimental Procedures of the Supplemental Information.
In Vivo Biotinylation
HeLa or HEK293T cells seeded in 6-well dishes were cotransfected with plasmids encoding substrate and BirA in a 4:1 ratio using Lipofectamine 2000 (Invitrogen). 16 hr after transfection, cells were radiolabeled with 150 mCi translabel for 1 hr (Emerman et al., 2010) , harvested in 1% SDS, 0.1 M Tris, pH 8 and immediately boiled to fully solubilize all proteins and destroy all enzymatic activities. Pulldowns and immunoprecipitations were performed as described (Emerman et al., 2010) on samples diluted 10-fold in ice cold IP buffer (1% Triton X-100, 50 mM HEPES, (pH 7.4), 100 mM NaCl). For proteasome inhibition and CaM inhibition, 10 mM MG132 and/or inhibitors were added during labeling.
Translation Extracts
Fr-RRL has been described (Hessa et al., 2011; see Extended Experimental Procedures) . N-RRL was made by reconstituting native RRL that had not been treated with hemin or nuclease into a translation system using the same final concentrations of components as the RRL and Fr-RRL translation systems (Hessa et al., 2011) . CaM-depleted translation extract was produced by passing native RRL over GST-tagged CaM binding peptide immobilized on a glutathione sepharose column and reconstituting the flow-through into a translation system. Detailed protocols are provided in Extended Experimental Procedures.
In Vitro Translation and Translocation
In vitro transcription and translation in RRL and Fr-RRL in the presence of 35 S-methionine were as described before for 30 min at 32 C (Stefanovic and Hegde, 2007; Hessa et al., 2011; Sharma et al., 2010) . Translation in N-RRL was the same as in RRL except that the translation extract was made with a completely 'native' RRL (i.e., nonnucleased and nonhemin treated). Final concentrations of all other additives remain the same. Thus, N-RRL contains the endogenous level of cytosolic Ca 2+ derived from the reticulocyte cytosol, and any trace amounts contributed by the water and other shelf chemicals. Cotranslational translocation assays into RMs have been described previously (Fons et al., 2003) . For posttranslational translocation assays, translation was terminated by either adding 10 mg/ml RNase A and/or by removing of ribosomes by ultracentrifugation (70,000 rpm in the TLA120.1 rotor (Beckman) for 30 min at 4 C). Translocation was initiated by adding RMs (derived from either canine or porcine pancreas; Walter and Blobel, 1983) . The addition of recombinant proteins and calcium and EGTA manipulations were as described in the individual figure legends. Unless otherwise noted, translocation assays were for 30 min at 32 C, except for those shown in Figure 7C , which were conducted at 37 C. Protease protection assay for translocated products was as before (Stefanovic and Hegde, 2007; Fons et al., 2003) . For immunoprecipitations or pulldowns, samples were first denatured by boiling to 100 C in 1% SDS, 0.1 M Tris, pH 8, then treated as described above for IPs or pulldowns from cultured cells. Translocation efficiencies were quantified with either Image J or by phosphorimaging using a Typhoon scanner. All band intensities were subtracted of background intensities and normalized for the number of methionines expected to be in the products.
Sucrose Gradients, Crosslinking, and Translocation
In most experiments, 200 ml translation reactions were layered on a 2 ml 5%-25% sucrose gradients in physiologic salt buffer (PSB: 50 mM Hepes, [pH 7.4], 100 mM KAc, 2 mM MgAc 2 ) and centrifuged for 5 hr at 55,000 rpm at 4 C in the TLS-55 rotor (Beckman). Eleven 200 ml fractions were then removed from the top. For translocation assays of sucrose gradient fractions, RMs were added (composing one tenth of the reaction volume), the reaction supplemented with an energy-regenerating system (1 mM ATP, 1 mM GTP, 10 mM Creatine phosphate, 40 mg/ml Creatine Kinase) and 1 mM DTT, and incubated for 30 min at 32 C. The remaining analysis was as above. Chemical crosslinking experiments of sucrose gradient fractions were performed with 250 mM DSS at room temperature for 30 min, quenched with 100 mM Tris, and samples were then subject to direct analysis or immunoprecipitation. For crosslinking of RRL, or N-RRL translation reactions, the samples were first diluted 10-fold in PSB (to dilute primary amines) before adding crosslinker as above. Fr-RRL was crosslinked directly since its buffer composition was known (see above) to lack primary amines. Photocrosslinking using benzophenone-modified or 4,4-azipentanoyl-modified lysyl-tRNA (from tRNA Probes) was as before (Do et al., 1996; Krieg et al., 1986) , except Fr-RRL was used for the translation and the suppressor tRNA was included in the translation reaction at a final concentration of 1 mM. Both probes gave similar site-specific and crosslinking efficiency results. Crosslinking time courses were performed by rapidly freezing samples in liquid nitrogen at the indicated time points and UV irradiating on dry ice (Plath et al., 2004) . Size fractionation of CecA and Prl in CaM-depleted lysates were on a 10%-50% sucrose gradient in PSB centrifuged at 55,000 rpm for 1 hr at 4 C in the TLS-55 rotor, after which 200 ml fractions were collected and analyzed directly.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, one table, and four figures and can be found with this article online at doi:10.1016/j.cell.2011.11.048.
ACKNOWLEDGMENTS
We are grateful to M. Mariappan for useful discussions; S. Appathurai for initial experiments and reagents; A. Sharma for technical help; other Hegde lab members for support; and K. Strub for sharing results prior to publication.
